I kliniske undersøgelser har man hos nogle få voksne patienter behandlet med simvastatin set vedvarende stigninger (op til > 3 x ULN) i serumtransaminaser.
In clinical studies, persistent increases (to > 3 x ULN) in serum transaminases have occurred in a few adult patients who received simvastatin.